top of page
About 67% of neurological patients develop gastrointestinal (GI) dysfunctions via the gut-brain-axis, complicating treatment and amplifying side effects. Across all GI care, prevention is crucial yet missing: failure of early disease detection drives roughly 37% additional caring costs for patients.
No market alternatives prioritize prevention nor provide neurological feedback; most also lack continuity and wearability—gaps we fill. Current gastric care is reactive, confirmatory, and one-way: standard modalities–biopsy, gastroscopy, and manometry--detect late-stage structural abnormalities, with no insight into related neurological conditions.
cr.Gastrocentre Hospital
bottom of page